Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and the governments of Ethiopia and the Netherlands, today signed a seven-year agreement to build Ethiopia's first specialized Cardiac Care Center to address the critical shortage of cardiology services in Ethiopia. Under the terms of the agreement, valued at approximately 40 million euro, Philips will be responsible for the full turnkey design, construction, equipping and commissioning of the hospital location, as well as staff education and equipment maintenance for five years after completion.
The Innovative Medicines Initiative (IMI) has launched its 100th project in the form of Hypo-RESOLVE, a 4 year, EUR 26.8 million project on diabetes. The milestone comes as IMI celebrates its 10th anniversary with a series of events and activities. The IMI project portfolio is diverse; many projects, like Hypo-RESOLVE, focus on specific health issues such as diabetes, neurological conditions (including dementia, depression, and pain), cancer, auto-immune diseases (such as rheumatoid arthritis), and infectious diseases (including antimicrobial resistance and Ebola).
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and US-based Emory Healthcare have launched a new remote Intensive Care Unit (eICU) monitoring program, based at the Royal Perth Hospital in Western Australia, focused on improving the outcomes of high risk patients and advancing the globalization of critical care.